KONEXMachinery208850

EB Tech

₩4,500 0.00%2026-11-18 close
Market Cap
₩12.7B
Turnover
₩0
Volume
0 shares
Shares out.
2.8M
PER
—
PBR
—
EPS
—
Dividend Yield
0.00%

PER, PBR and dividend yield are calculated from the latest confirmed results (EPS, BPS, dividend per share) and the current share price · Prices as of the 2026-11-18 close

01

Report overview

Earnings growth amid thin trading on KONEX

EB Tech grew sales and operating profit in 2025, but its operating cash flow fell sharply, making cash conversion the central issue.

  1. 1

    2025 sales reached about KRW 129.2 billion and operating profit about KRW 27.1 billion, both higher than the prior year.

  2. 2

    The operating margin rose from 9.4% in 2023 to 14.2% in 2024 and 21.0% in 2025.

  3. 3

    Operating cash flow fell from KRW 2.93 billion in 2024 to about KRW 0.42 billion in 2025.

  4. 4

    The stock traded at KRW 4,200 with zero trading value at the time of writing, reflecting very thin liquidity.

  5. 5

    Because the tangible asset acquisition decision was followed by two corrective filings, the corrected acquisition amount and purpose are the next points to check.

02

Business structure

EB Tech is an electron accelerator manufacturer spun off from Samsung Heavy Industries in 2000, and it listed on the KONEX market on June 22, 2016. Its business runs on two lines, the production and sale of electron accelerators and electron beam irradiation services.

The company says electron beams are used in wire, heat-shrink tubing, tires, foamed resins, semiconductor processes, food sterilization and medical product sterilization. Equipment sales move with customers' capital investment timing. Irradiation services are recurring in nature and track customers' production volumes.

The company describes itself as the only electron accelerator maker in Korea, which suggests a limited domestic supply competition. Price and technology comparisons with overseas equipment makers are difficult to quantify from public data alone.

Demand spans industrial materials and medical and food sterilization, so the business is not concentrated in a single end market. Equipment sales can make quarterly results lumpy depending on order timing.

As of December 31, 2025, the company had 44 employees, so a small team runs both manufacturing and irradiation services.

03

Recent trends

Sales in 2025 were KRW 129.2 billion, up 21.0% from KRW 106.7 billion in 2024, based on DART-filed data compiled by Saramin and JobKorea. Sales rose for three straight years from 2023, after KRW 65.4 billion in 2022 and KRW 80.6 billion in 2023.

Operating profit reached about KRW 27.1 billion in 2025, up 79.3% from KRW 15.1 billion, and the operating margin rose to 21.0%. The margin had been 9.4% in 2023 and 14.2% in 2024, so it rose in two consecutive years. Net income for 2025 was about KRW 2.6 billion, compared with about KRW 1.7 billion in 2024.

Equity grew to about KRW 15.1 billion, with an equity ratio of 83.66% and a borrowing dependence of 8.30%. Operating cash flow, however, fell sharply from about KRW 2.9 billion in 2024 to about KRW 0.4 billion in 2025.

Cash operating profit also contracted from about KRW 2.7 billion to about KRW 0.5 billion over the same period. The gap between rising profit and weaker cash generation is the key issue in the 2025 results.

According to press reports, the stock was at KRW 4,800 as of 16:10 on March 30, 2026, and it closed at KRW 4,200 as of November 11, 2026.

04

Outlook

The starting point for reading future results is whether the operating profit expanded in 2025 converts into cash. Whether the drop in operating cash flow to the KRW 0.4 billion range stems from working capital build or one-off factors will shape how profit quality is assessed after 2026.

A tangible asset acquisition decision was disclosed on June 9, 2026, followed by corrective filings on the same day and on September 30, 2026. Whether these acquisitions lead to expanded production capacity or new equipment lines will be the turning point for the medium-term sales outlook.

At the annual general meeting on March 30, 2026, the financial statements, a board member re-election and the director pay limit were all approved. The financial statements approved at that meeting underpin the 2025 results.

An investor relations event was held on June 9, 2026, and its outcome was disclosed on June 25, so IR activity is continuing. The 2026 business report is due by the end of March 2027 under the standard filing deadline.

With trading value close to zero, price signals are likely to be shaped more by thin trading than by individual results. On the demand side, investment cycles in power equipment and semiconductor facilities act as indirect variables.

05

Bull factors

Sustained sales growth

EB Tech's sales roughly doubled from about KRW 65.4 billion in 2022 to about KRW 129.2 billion in 2025, based on DART-filed data. Sales grew for three consecutive years from 2023, and the 2025 growth rate was 21.0%.

The company says its electron beams serve wire, tire, semiconductor, food and medical sterilization uses, so demand is not tied to one industry. This breadth is cited as a factor supporting sales continuity.

Margin improvement and financial headroom

The operating margin rose from 9.4% in 2023 to 21.0% in 2025. The 2025 equity ratio was 83.66% and borrowing dependence was 8.30%, indicating a comparatively comfortable balance sheet. ROE was 18.98% in 2025, up from 13.12% in 2024. Whether the margin gain is temporary or structural will be clarified by subsequent results.

Domestic supply position and capacity signals

The company describes itself as the only electron accelerator manufacturer in Korea. That position gives it a supply advantage when domestic equipment demand emerges. A tangible asset acquisition decision was disclosed on June 9, 2026, and corrective filings followed afterward. The scale and purpose of the acquisition should be read from the original disclosure.

06

Bear factors

Sharp drop in operating cash flow

Operating cash flow dropped sharply in 2025 from the prior year, based on DART-filed data, so cash inflow lagged behind profit growth. Cash operating profit contracted from about KRW 2.71 billion to about KRW 0.53 billion over the same period. Book profit growth and cash generation moved in opposite directions. The assessment of profit quality depends on whether working capital build is the cause.

Thin trading and share price decline

Trading value was shown as zero at the time of writing, which points to very low liquidity. The share price, reported at KRW 4,800 on March 30, 2026, was KRW 4,200 as of November 11, 2026. Compared with the all-time high of KRW 14,800 recorded on March 29, 2017, the decline has accumulated over time.

Concentration and scale constraints

The company had 44 employees as of December 31, 2025, which is a small operation. Its business is concentrated around electron accelerators, making it sensitive to equipment investment cycles. Equipment sales can cause quarterly results to swing depending on order timing.

07

Risk factors

Macro

A slowdown in domestic and overseas capital investment could reduce electron beam equipment orders from customers in wire, tire and semiconductor industries. Interest rate and exchange rate movements indirectly affect the timing of equipment purchases and customer investment decisions. Raw material and component price changes could also affect the cost structure.

Industry

Limited domestic competition is an advantage, but alternative technologies or entry by overseas equipment makers could affect market share. Changes in radiation safety regulations and equipment approval conditions could influence operating costs and order intake. Equipment replacement cycles and customers' production plans also shape revenue visibility.

Liquidity

Trading value shown as zero points to a thin trading base, which limits the informational value of price moves. KONEX-listed stocks generally have a narrow participant base, so price formation tends to be constrained. For a small company, the frequency and content of disclosures become the main basis for market assessment.

08

Overall view

EB Tech grew both sales and profitability in 2025, with sales of about KRW 129.2 billion and operating profit of about KRW 27.1 billion. A 21.0% operating margin and an 83.66% equity ratio are the main financial strengths.

Operating cash flow, however, fell to about KRW 0.4 billion in the same year, weakening the link between profit and cash and forming the largest bear factor. According to the company, it is the only electron accelerator maker in Korea, and its diversified end markets are cited as a base for medium-term growth.

With 44 employees and a business centered on electron accelerators, however, the company remains exposed to equipment investment cycles and order timing.

As a KONEX-listed stock with zero trading value, and with the share price moving from KRW 4,800 on March 30, 2026 to KRW 4,200 on November 11, 2026, price signals are harder to interpret.

Overall, strengths in earnings growth and financial headroom coexist with weaknesses in cash flow deterioration and thin liquidity, and the direction cannot be determined with confidence from the current information set.

09

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 5 more articles and sources
  1. saramin.co.kr
  2. jobkorea.co.kr
  3. incruit.com
  4. jlab.incruit.com
  5. m.news.nate.com

Report written 2026-11-11 · Data as of 2026-11-10

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis